Carole Seguin-Devaux

17PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Host-parasite interactionsMedical molecular engineering of nucleic acids and proteinsEpidemiological methodsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 12, 2025
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer.

Carole Seguin-Devaux, Bianca Brandus, Jean-Marc Plesseria

|Mar 27, 2025
Fighting Antibiotic Resistance: Insights Into Human Barriers and New Opportunities: Antibiotic Resistance Constantly Rises With the Development of Human Activities. We discuss Barriers and Opportunities to Get It Under Control.

Aubin Pitiot, Camille Rolin, Carole Seguin-Devaux

|Nov 27, 2024
Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine.

Pavithra Nagarajan, Jinru Zhou, Giulia Di Teodoro

|Dec 23, 2023
The Role of Late Presenters in HIV-1 Transmission Clusters in Europe.

Mafalda N S Miranda, Victor Pimentel, Perpétua Gomes

|Nov 07, 2023
Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure.

Rafaëla Schober, Bianca Brandus, Thessa Laeremans

|Oct 14, 2023
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.

Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen

Pageof 3

Frequent Collaborators

4 joint publications

Ana B Abecasis

4 joint publications

Maurizio Zazzi

3 joint publications

Francesca Incardona

3 joint publications

Danielle Perez-Bercoff